| Bioactivity | UCM-13207 (compound 21) is a selective ICMT inhibitor that ameliorates basic progeria-like features. UCM-13207 can improve the survival rate of LmnaG609G/G609G mice in the mouse premature aging model[1]. |
| Name | UCM-13207 |
| CAS | 1621536-10-4 |
| Formula | C24H32N2O2 |
| Molar Mass | 380.52 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Marcos-Ramiro B et al. Isoprenylcysteine carboxylmethyltransferase-based therapy for Hutchinson–Gilford progeria syndrome[J]. ACS Central Science, 2021, 7(8): 1300-1310. |
UCM-13207
CAS: 1621536-10-4 F: C24H32N2O2 W: 380.52
UCM-13207 (compound 21) is a selective ICMT inhibitor that ameliorates basic progeria-like features. UCM-13207 can impro
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.